ArticleCancers2026

Baseline Systemic Inflammation Response Index and Clinical Outcomes in Heavily Pretreated Platinum-Resistant Ovarian Cancer Treated with Pembrolizumab Monotherapy.

Seongyun Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.